Silencing of claudin-11 is associated with increased invasiveness of gastric cancer cells

PLoS ONE

Volumn 4, Issue 11, 2009, Pages

  Agarwal, Rachana ^a   Mori, Yuriko ^a   Cheng, Yulan ^a   Jin, Zhe ^a   Olaru, Alexandru V ^a   Hamilton, James P ^a   David, Stefan ^a   Selaru, Florin M ^a   Yang, Jian ^a   Abraham, John M ^a   Montgomery, Elizabeth ^a   Morin, Patrice J ^b   Meltzer, Stephen J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 11; MESSENGER RNA; SMALL INTERFERING RNA; 5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; CLDN11 PROTEIN, HUMAN; DRUG DERIVATIVE; NERVE PROTEIN; TUMOR MARKER;

ARTICLE; CANCER CELL; CANCER INVASION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN TISSUE; METHYLATION; PHENOTYPE; POLYMERASE CHAIN REACTION; PROMOTER REGION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH EPITHELIUM; CELL MOTION; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; STOMACH TUMOR; TUMOR CELL LINE;

AZACITIDINE; CELL LINE, TUMOR; CELL MOVEMENT; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; NEOPLASM INVASIVENESS; NERVE TISSUE PROTEINS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 71049120285     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008002     Document Type: Article

References (40)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
2. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, et al. (2003) Cancer statistics, 2003. CA Cancer J Clin 53: 5-26.
3. Rhyu MG, Park WS, Meltzer SJ (1994) Microsatellite instability occurs frequently in human gastric carcinoma. Oncogene 9: 29-32.
4. Tamura G, Sakata K, Maesawa C, Suzuki Y, Terashima M, et al. (1995) Microsatellite alterations in adenoma and differentiated adenocarcinoma of the stomach. Cancer Res 55: 1933-1936.
5. Schmutte C, Baffa R, Veronese LM, Murakumo Y, Fishel R (1997) Human thymine-DNA glycosylase maps at chromosome 12q22-q24.1: a region of high loss of heterozygosity in gastric cancer. Cancer Res 57: 3010-3015.
6. Fukudome Y, Yanagihara K, Takeichi M, Ito F, Shibamoto S (2000) Characterization of a mutant E-cadherin protein encoded by a mutant gene frequently seen in diffuse-type human gastric carcinoma. Int J Cancer 88: 579-583.
7. Jones PA, Baylin SB (2007) The epigenomics of cancer. Cell 128: 683-692.
8. Toyota M, Ahuja N, Suzuki H, Itoh F, Ohe-Toyota M, et al. (1999) Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 59: 5438-5442.
9. Machado JC, Oliveira C, Carvalho R, Soares P, Berx G, et al. (2001) E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 20: 1525-1528.
10. Leung SY, Yuen ST, Chung LP, Chu KM, Chan AS, et al. (1999) hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res 59: 159-164.
11. Lee YY, Kang SH, Seo JY, Jung CW, Lee KU, et al. (1997) Alterations of p16INK4A and p15INK4B genes in gastric carcinomas. Cancer 80: 1889-1896.
12. Fleisher AS, Esteller M, Wang S, Tamura G, Suzuki H, et al. (1999) Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res 59: 1090-1095.
13. Kang GH, Shim YH, Ro JY (1999) Correlation of methylation of the hMLH1 promoter with lack of expression of hMLH1 in sporadic gastric carcinomas with replication error. Lab Invest 79: 903-909.
14. Suzuki H, Itoh F, Toyota M, Kikuchi T, Kakiuchi H, et al. (1999) Distinct methylation pattern and microsatellite instability in sporadic gastric cancer. Int J Cancer 83: 309-313.
15. Tamura G, Yin J, Wang S, Fleisher AS, Zou T, et al. (2000) E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 92: 569-573.
16. Morin PJ (2005) Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 65: 9603-9606.
17. Weinstein RS, Merk FB, Alroy J (1976) The structure and function of intercellular junctions in cancer. Adv Cancer Res 23: 23-89.
18. Hewitt KJ, Agarwal R, Morin PJ (2006) The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 6: 186.
19. Kominsky SL, Argani P, Korz D, Evron E, Raman V, et al. (2003) Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 22: 2021-2033.
20. Nakayama F, Semba S, Usami Y, Chiba H, Sawada N, et al. (2008) Hypermethylation-modulated downregulation of claudin-7 expression promotes the progression of colorectal carcinoma. Pathobiology 75: 177-185.
21. Osanai M, Murata M, Chiba H, Kojima T, Sawada N (2007) Epigenetic silencing of claudin-6 promotes anchorage-independent growth of breast carcinoma cells. Cancer Sci 98: 1557-1562.
22. Honda H, Pazin MJ, D'Souza T, Ji H, Morin PJ (2007) Regulation of the CLDN3 gene in ovarian cancer cells. Cancer Biol Ther 6: 1733-1742.
23. Honda H, Pazin MJ, Ji H, Wernyj RP, Morin PJ (2006) Crucial roles of Sp1 and epigenetic modifications in the regulation of the CLDN4 promoter in ovarian cancer cells. J Biol Chem 281: 21433-21444.
24. David S, Kan T, Cheng Y, Agarwal R, Jin Z, et al. (2009) Aberrant silencing of the endocrine peptide gene tachykinin-1 in gastric cancer. Biochem Biophys Res Commun 378: 605-609.
25. Agarwal R, D'Souza T, Morin PJ (2005) Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res 65: 7378-7385.
26. Leotlela PD, Wade MS, Duray PH, Rhode MJ, Brown HF, et al. (2007) Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility. Oncogene 26: 3846-3856.
27. Dhawan P, Singh AB, Deane NG, No Y, Shiou SR, et al. (2005) Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest 115: 1765-1776.
28. Lui WY, Wong EW, Guan Y, Lee WM (2007) Dual transcriptional control of claudin-11 via an overlapping GATA/NF-Y motif: positive regulation through the interaction of GATA, NF-YA, and CREB and negative regulation through the interaction of Smad, HDAC1, and mSin3A. J Cell Physiol 211: 638-648.
29. Mullin JM (1997) Potential interplay between luminal growth factors and increased tight junction permeability in epithelial carcinogenesis. J Exp Zool 279: 484-489.
30. Martin TA, Jiang WG (2001) Tight junctions and their role in cancer metastasis. Histol Histopathol 16: 1183-1195.
31. Sanada Y, Oue N, Mitani Y, Yoshida K, Nakayama H, et al. (2006) Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype. J Pathol 208: 633-642.
32. Katoh M (2003) CLDN23 gene, frequently down-regulated in intestinal-type gastric cancer, is a novel member of CLAUDIN gene family. Int J Mol Med 11: 683-689.
33. Cunningham SC, Kamangar F, Kim MP, Hammoud S, Haque R, et al. (2006) Claudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions. Cancer Epidemiol Biomarkers Prev 15: 281-287.
34. Bronstein JM, Popper P, Micevych PE, Farber DB (1996) Isolation and characterization of a novel oligodendrocyte-specific protein. Neurology 47: 772-778.
35. Morita K, Sasaki H, Fujimoto K, Furuse M, Tsukita S (1999) Claudin-11/ OSP-based tight junctions of myelin sheaths in brain and Sertoli cells in testis. J Cell Biol 145: 579-588.
36. Gow A, Southwood CM, Li JS, Pariali M, Riordan GP, et al. (1999) CNS myelin and sertoli cell tight junction strands are absent in Osp/ claudin-11 null mice. Cell 99: 649-659.
37. Fink C, Weigel R, Fink L, Wilhelm J, Kliesch S, et al. (2009) Claudin-11 is over-expressed and dislocated from the blood-testis barrier in Sertoli cells associated with testicular intraepithelial neoplasia in men. Histochem Cell Biol.
38. Michl P, Barth C, Buchholz M, Lerch MM, Rolke M, et al. (2003) Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res 63: 6265-6271.
39. Itoh M, Furuse M, Morita K, Kubota K, Saitou M, et al. (1999) Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol 147: 1351-1363.
40. Zahraoui A, Louvard D, Galli T (2000) Tight junction, a platform for trafficking and signaling protein complexes. J Cell Biol 151: F31-36.